Fr
Da
En
De
Sv
Opérations
Qui sommes-nous ?
L’entreprise
Equipe
Nos bureaux
Globalscope
Newsletter
Services
Corporate Finance
Conseil en matière de dette
Equity Research
Levées de Fonds – Séries A, B, C ….
Stratégie et préparation de l’introduction en bourse
Industries
Services aux Entreprises
Consumer / Retail / E-commerce
Technologie industrielle
Life science et Santé
Software / TMT
Research
Equity Research
Macro and markets
Career
Evénements
Insights
News
Company News
Deal News
Carlsquare in the Media
Newsletter
Contactez-nous
Newsletter
Fr
Da
En
De
Sv
Main menu button
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Equipe
Opérations
Contact
Worldwide
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Equipe
Opérations
Contact
Actualités
Tout
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Tout
Company News
Deal News
Equity Research
Events
Insights
Macro and markets
Media
28 Fév 2024
Equity Research Mindark PE, Q4 2023: Adjusted accounting principles contribute to high net revenues
Equity Research
Mindark PE
07 Déc 2023
Equity Research Mindark PE, Q3 2023: Growth as expected
Equity Research
Mindark PE
28 Nov 2023
Equity Research Mindark PE, First impression Q3 2023: Revenues as expected, but still high capitalized development costs
Equity Research
Mindark PE
04 Oct 2023
Initiation of coverage Mindark PE: Renewal and improvements followed by growth
Equity Research
Mindark PE